140 related articles for article (PubMed ID: 2462612)
1. Modulation of HLA class II antigen expression by transfection of sense and antisense DR alpha cDNA.
Lotteau V; Sands J; Teyton L; Turmel P; Charron D; Strominger JL
J Exp Med; 1989 Jan; 169(1):351-6. PubMed ID: 2462612
[TBL] [Abstract][Full Text] [Related]
2. A novel HLA class II molecule (DR alpha-DQ beta) created by mismatched isotype pairing.
Lotteau V; Teyton L; Burroughs D; Charron D
Nature; 1987 Sep 24-30; 329(6137):339-41. PubMed ID: 3306409
[TBL] [Abstract][Full Text] [Related]
3. Structural requirements for pairing of alpha and beta chains in HLA-DR and HLA-DP molecules.
Karp DR; Teletski CL; Jaraquemada D; Maloy WL; Coligan JE; Long EO
J Exp Med; 1990 Mar; 171(3):615-28. PubMed ID: 2307929
[TBL] [Abstract][Full Text] [Related]
4. An isotype-specific trans-acting factor is defective in a mutant B cell line that expresses HLA-DQ, but not -DR or -DP.
Ono SJ; Bazil V; Sugawara M; Strominger JL
J Exp Med; 1991 Mar; 173(3):629-37. PubMed ID: 1997650
[TBL] [Abstract][Full Text] [Related]
5. Differential surface expression of class II isotypes on activated CD4 and CD8 cells correlates with levels of locus-specific mRNA.
Diedrichs M; Schendel DJ
J Immunol; 1989 May; 142(9):3275-80. PubMed ID: 2785139
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
7. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
8. Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes.
Liu CP; Bach FH; Wu SK
J Immunol; 1988 May; 140(10):3631-9. PubMed ID: 3129499
[TBL] [Abstract][Full Text] [Related]
9. [Differential expression of HLA DR, DP and DQ in cultivated, human ciliary body epithelial cells].
Helbig H; Kittredge KL; Coca-Prados M; Nussenblatt RB
Fortschr Ophthalmol; 1991; 88(3):295-8. PubMed ID: 1889783
[TBL] [Abstract][Full Text] [Related]
10. Regulation of HLA-DR, DP, and DQ expression in activated T cells.
Gansbacher B; Zier KS
Cell Immunol; 1988 Nov; 117(1):22-34. PubMed ID: 3263216
[TBL] [Abstract][Full Text] [Related]
11. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a specific post-transcriptional mechanism controlling the expression of HLA-DQ, but not -DR and -DP, molecules.
De Lerma Barbaro A; Sartoris S; Tosi G; Nicolis M; Accolla RS
J Immunol; 1994 Nov; 153(10):4530-8. PubMed ID: 7525708
[TBL] [Abstract][Full Text] [Related]
13. Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer.
Jo YS; Lee JC; Li S; Choi YS; Bai YS; Kim YJ; Lee IS; Rha SY; Ro HK; Kim JM; Shong M
Int J Cancer; 2008 Feb; 122(4):785-90. PubMed ID: 17957790
[TBL] [Abstract][Full Text] [Related]
14. HLA-DR and DQ antigens in chronic lymphocytic leukemia: dissociation of expression revealed by cell surface, protein, and mRNA studies.
Kraïba R; Loiseau P; Faille A; Poirier O; Piatier-Tonneau D; Degos L; Abita JP; Charron D
Leukemia; 1989 May; 3(5):386-93. PubMed ID: 2497283
[TBL] [Abstract][Full Text] [Related]
15. Expression of MHC class II antigens on human glioma cells modulated by transfection with genes encoding these antigens.
Yoshida S; Takahashi H; Tanaka R
Neurol Med Chir (Tokyo); 1991 Oct; 31(10):623-8. PubMed ID: 1725809
[TBL] [Abstract][Full Text] [Related]
16. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
[TBL] [Abstract][Full Text] [Related]
18. HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis.
Haegert DG; Michaud M; Schwab C; Tansey C; Décary F; Francis G
J Neurosci Res; 1989 May; 23(1):46-54. PubMed ID: 2568496
[TBL] [Abstract][Full Text] [Related]
19. The properties of the single chicken MHC classical class II alpha chain ( B-LA) gene indicate an ancient origin for the DR/E-like isotype of class II molecules.
Salomonsen J; Marston D; Avila D; Bumstead N; Johansson B; Juul-Madsen H; Olesen GD; Riegert P; Skjødt K; Vainio O; Wiles MV; Kaufman J
Immunogenetics; 2003 Dec; 55(9):605-14. PubMed ID: 14608490
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]